Please note that the dosage frequency for these codes are 4 weeks and not 3 weeks as printed in the Tiered Oncology Guidelines.
The correct codes are as follows -
X113 Temozolomide 200mg/m2/day po d1-5 every 4 weeks x 6.
X1032 Temozolomide 75mg/m2/d during RT; then Temozolomide 200mg/m2/d po d1-5 every 4 weeks post RT x 6.
Back to the Bulletin Board
It is all about Quality Cancer Care.
